{"id":93,"date":"2024-06-26T13:50:39","date_gmt":"2024-06-26T13:50:39","guid":{"rendered":"https:\/\/www.merckvaccines.com\/vaxneuvance\/?page_id=93"},"modified":"2026-02-23T09:29:39","modified_gmt":"2026-02-23T09:29:39","slug":"recommendations","status":"publish","type":"page","link":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/","title":{"rendered":"Recommendations"},"content":{"rendered":"\n\n
<\/div>\"\"<\/picture>

VAXNEUVANCE is a CDC recommended option<\/span> for all<\/em> of your appropriate pediatric patients1<\/sup><\/strong><\/strong><\/h1>

<\/p>

<\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div>\n\n\n\n\n
<\/div>\n\n\n\n\n

The CDC, AAP, and AAFP recommend the use of VAXNEUVANCE as an option for routine vaccination in infants and children, as well as for vaccination in children with certain medical conditions.1-3<\/sup><\/strong><\/strong><\/h2><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n\n
\"\"<\/figure><\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n

A CDC recommended option1<\/sup><\/strong><\/h3><\/div>\n\n\n\n
<\/div>\n\n\n\n

The ACIP recommends VAXNEUVANCE (PCV15) and PCV20 at parity for routine vaccination of healthy pediatric patients<\/p><\/div><\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure><\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n

CDC recommendation on interchangeability1<\/sup><\/strong><\/strong><\/h3><\/div>\n\n\n\n
<\/div>\n\n\n\n

VAXNEUVANCE is a CDC recommended option for a 4-dose series<\/a> or for completion of a 4-dose series initiated with another PCV<\/p><\/div><\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure><\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n

Proactively studied in certain at-risk populations1-3,a<\/sup><\/strong><\/strong><\/strong><\/h3><\/div>\n\n\n\n
<\/div>\n\n\n\n

VAXNEUVANCE is a CDC, AAP, and AAFP recommended PCV with specifically designed clinical studies of pediatric populations with certain risk conditions<\/a><\/p><\/div><\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n\n\n\n

a<\/sup>Pediatric populations with risk conditions were preterm infants, children living with HIV or SCD (immunocompromising diseases), or children who had received an allo-HSCT (an immunocompromising condition): preterm infants, <37 weeks gestation at birth; children living with HIV, 6\u201317 years of age; children living with SCD, 5\u201317 years of age; and recipients of allo-HSCT, 3\u201317 years of age.<\/p>\n\n\n\n

<\/div>\n\n\n\n

VAXNEUVANCE is available through the VFC Program4<\/sup><\/strong><\/h2><\/div>\n\n\n\n
<\/div>\n\n\n\n\n
\n

You have brand choice\u2014choose VAXNEUVANCE for your patients enrolled in the Vaccines for Children Program.<\/strong>4,5<\/strong><\/sup><\/p><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n

\n

Parents and caregivers of your pediatric patients may be unaware of vaccination programs, such as the VFC Program. VFC is a federally funded vaccine program that provides recommended vaccines to eligible children and adolescents who might not otherwise be able to afford them.5<\/sup><\/p>\n<\/div><\/div><\/div>\n\n\n\n

<\/div>\n\n\n\n
<\/div>\n\n\n\n\n
\n\n\n\n
\n
<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n
\"\"<\/figure><\/div><\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n

As of December 2024,<\/strong><\/p>\n\n\n\n

100%*<\/strong><\/p><\/div><\/div>\n\n\n\n

\n\n\n\n

of commercially insured pediatric patients are insured by a plan that has approved coverage for VAXNEUVANCE6,b,c<\/sup><\/strong><\/p><\/div><\/div>\n\n\n\n

\n\n\n\n
<\/div>\n\n\n\n

b<\/sup>Total Medical Lives (N=140,526,677) and VAXNEUVANCE Covered Lives (N=140,526,677).<\/p>\n\n\n\n

c<\/sup>Data, from Clarivate, are as of December 2024 and reflect coverage under the commercial medical benefit.<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n

*<\/sup>Payers with coverage as N\/A (not available\/confirmed) have been removed from both the Total Medical Lives and the VAXNEUVANCE Covered Lives, and therefore are not represented in this percentage.<\/p>\n\n\n\n

<\/div>\n\n\n\n

The information reflected here is subject to change at any time.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Additionally, this information is not inclusive of all plans that have made a decision regarding coverage for VAXNEUVANCE. You should contact your patient’s health plan directly for information on coverage and out-of-pocket costs to ensure that you have the most timely and accurate information.<\/p>\n\n\n\n

<\/div>\n\n\n\n

The information provided does not guarantee that a decision on coverage will result in out-of-pocket costs being covered.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Coverage for VAXNEUVANCE is dependent on the terms and conditions of your patient’s insurance benefit, including any applicable deductible or cap. Additionally, there may be a co-pay or coinsurance that applies. A health plan\u2019s decision to cover VAXNEUVANCE does not guarantee that implementation at the regional\/local level has occurred or will necessarily occur.<\/p>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div><\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Looking to stock VAXNEUVANCE in your practice?<\/strong><\/h4><\/div>\n\n\n\n
<\/div>\n\n\n\n

Simply register or log into your account to get started.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n
Order VAXNEUVANCE<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

AAP, American Academy of Pediatrics; AAFP, American Academy of Family Physicians; ACIP, Advisory Committee on Immunization Practices; allo-HSCT, allogeneic hematopoietic stem cell transplant; CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus; PCV; pneumococcal conjugate vaccine; PCV15, 15-valent pneumococcal conjugate vaccine; PCV20, 20-valent pneumococcal conjugate vaccine; SCD, sickle cell disease; VFC, Vaccines for Children.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n\n
<\/i><\/div>

View safety & tolerability data<\/strong><\/h3>

View safety & tolerability data<\/a><\/p><\/div>

<\/i><\/div><\/div><\/div><\/div>\n<\/div>\n\n\n\n
\n
<\/i><\/div>

Discover resources for your practice<\/strong><\/h3>

Discover resources for your practice<\/a><\/p><\/div>

<\/i><\/div><\/div><\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
<\/i><\/div>

Stay updated on serotypes<\/strong><\/h3>

Stay updated on serotypes<\/a><\/p><\/div>

<\/i><\/div><\/div><\/div><\/div>\n<\/div>\n\n\n\n
\n
<\/i><\/div>

Get details on early disease protection<\/strong><\/h3>

Get details on early disease protection<\/a><\/p><\/div>

<\/i><\/div><\/div><\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

References:<\/strong><\/h2><\/div>\n\n\n\n\n
\n
    \n
  1. Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2025. Revised October 7, 2025. Accessed October 12, 2025. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf<\/li>\n\n\n\n
  2. Immunization schedule. American Academy of Pediatrics. Last updated September 17, 2025. Accessed September 30, 2025. AAP.org\/immunizationschedule<\/li>\n\n\n\n
  3. American Academy of Family Physicians. Birth Through Age 18 Immunization Schedule. Last updated August 28, 2025. Accessed October 3, 2025. https:\/\/www.aafp.org\/family-physician\/patient-care\/prevention-wellness\/immunizations-vaccines\/immunization-schedules\/birth-through-age-18-immunization-schedule.html<\/li>\n\n\n\n
  4. Centers for Disease Control and Prevention (CDC). VFC. CDC Vaccine Price List. Updated October 6, 2025. Accessed October 10, 2025. https:\/\/www.cdc.gov\/vaccines-for-children\/php\/awardees\/current-cdc-vaccine-price-list.html<\/span><\/li>\n\n\n\n
  5. Centers for Disease Control and Prevention. About the Vaccines for Children (VFC) Program. Reviewed June 26, 2024. Accessed October 10, 2025. https:\/\/www.cdc.gov\/vaccines-for-children\/about\/index.html<\/span><\/li>\n\n\n\n
  6. Data available on request from the Merck National Service Center via email at daprequests@merck.com. Please specify information package US-PVC-02062.<\/li>\n<\/ol>\n<\/div>\n\n\n\n\n
    ExternalSitePopup<\/span><\/div>
    <\/i><\/a>

    By clicking on this link, you will be leaving Merck Vaccines.<\/h2><\/div>
    <\/div>
    Cancel<\/a><\/div>
    Proceed<\/a><\/div><\/div><\/div><\/div>
    Cancel<\/a><\/div>
    Proceed<\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

    The ACIP recommends VAXNEUVANCE (PCV15) and PCV20 at parity for routine vaccination of healthy pediatric patients VAXNEUVANCE is a CDC recommended option…<\/p>\n","protected":false},"author":708,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_trash_the_other_posts":false,"editor_notices":[],"footnotes":""},"ga4_page_audience":[1166],"ga4_page_birn_id":[],"ga4_page_branding":[227],"ga4_page_businessunit":[235],"ga4_page_campaign":[],"ga4_page_content_purpose":[257],"ga4_page_customer_journey_stage":[295],"ga4_page_customer_specialty":[359],"ga4_page_experience":[],"ga4_page_indication":[1215],"ga4_page_material_intent":[575],"ga4_page_product":[777],"ga4_page_region":[1025],"ga4_page_therapeuticarea":[1120],"class_list":["post-93","page","type-page","status-publish"],"yoast_head":"\nCDC, AAP, and AAFP Recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine)<\/title>\n<meta name=\"description\" content=\"Review the CDC, AAP, and AAFP recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine) for appropriate patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDC, AAP, and AAFP Recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine)\" \/>\n<meta property=\"og:description\" content=\"Review the CDC, AAP, and AAFP recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine) for appropriate patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/\" \/>\n<meta property=\"og:site_name\" content=\"vaxneuvance-pediatric-mv\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T09:29:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-content\/uploads\/sites\/173\/2024\/08\/Recommendations-Header_Desktop.webp?w=1536\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CDC, AAP, and AAFP Recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine)","description":"Review the CDC, AAP, and AAFP recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine) for appropriate patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/","og_locale":"en_US","og_type":"article","og_title":"CDC, AAP, and AAFP Recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine)","og_description":"Review the CDC, AAP, and AAFP recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine) for appropriate patients.","og_url":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/","og_site_name":"vaxneuvance-pediatric-mv","article_modified_time":"2026-02-23T09:29:39+00:00","og_image":[{"url":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-content\/uploads\/sites\/173\/2024\/08\/Recommendations-Header_Desktop.webp?w=1536","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/","url":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/","name":"CDC, AAP, and AAFP Recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine)","isPartOf":{"@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/#primaryimage"},"image":{"@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-content\/uploads\/sites\/173\/2024\/08\/Recommendations-Header_Desktop.webp?w=1536","datePublished":"2024-06-26T13:50:39+00:00","dateModified":"2026-02-23T09:29:39+00:00","description":"Review the CDC, AAP, and AAFP recommendations for VAXNEUVANCE\u00ae (Pneumococcal 15-valent Conjugate Vaccine) for appropriate patients.","breadcrumb":{"@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/#primaryimage","url":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-content\/uploads\/sites\/173\/2024\/08\/Recommendations-Header_Desktop.webp","contentUrl":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-content\/uploads\/sites\/173\/2024\/08\/Recommendations-Header_Desktop.webp","width":1145,"height":278},{"@type":"BreadcrumbList","@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/recommendations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.merckvaccines.com\/vaxneuvance\/"},{"@type":"ListItem","position":2,"name":"Recommendations"}]},{"@type":"WebSite","@id":"https:\/\/www.merckvaccines.com\/vaxneuvance\/#website","url":"https:\/\/www.merckvaccines.com\/vaxneuvance\/","name":"vaxneuvance-pediatric-mv","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.merckvaccines.com\/vaxneuvance\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/pages\/93","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/users\/708"}],"replies":[{"embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/comments?post=93"}],"version-history":[{"count":83,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/pages\/93\/revisions"}],"predecessor-version":[{"id":2940,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/pages\/93\/revisions\/2940"}],"wp:attachment":[{"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/media?parent=93"}],"wp:term":[{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_audience?post=93"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_birn_id?post=93"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_branding?post=93"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_businessunit?post=93"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_campaign?post=93"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=93"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=93"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=93"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_experience?post=93"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_indication?post=93"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_material_intent?post=93"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_product?post=93"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_region?post=93"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaxneuvance\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=93"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}